Ibrahim Hakan BUCAK, Mehmet BÜLBÜL

MgSO4 prophylaxis for obstetric reasons: Traditional solutions vs ready-made solutions

Aim: Magnesium (Mg) is frequently used in obstetrics as an anticonvulsant and neuroprotection in daily practice. Although readymadesolutions are produced today, health care workers still prepare and use MgSO4 via traditional methods. We planned this studyto investigate the possible benefits of using ready-made solutions.Material and Methods: The solution prepared by traditional methods was compared to a ready-made solution in terms of Mg amount,preparation duration and cost over time.Results: Ready-made solutions resulted in a more homogeneous infusion (386.98±25.30 vs 402.65±21.68), lower cost (6.86 vs 5.56)and less labor loss (1258 (min: 900 – max: 1500) vs 0 sec).Conclusions: This study, it does show that the use of a ready-made solution allows the patient to receive a more homogenousinfusion of magnesium over time, and it is more financially profitable. The use of ready-made MgSO4 solution also prevents the lossof time in the labor force that would have been spent preparing the solution.

PDF

___

1. Gupta K, Vohra V, Sood J. The role of magnesium as an adjuvant during general anaesthesia. Anaesthesia 2006;61:1058-63.
2. Gröber U, Schmidt J, Kisters K. Magnesium in prevention and therapy. Nutrients 2015;7:8199-226.
3. Hilmy MI, Somjen GG. Distribution and tissue uptake of magnesium related to its pharmacological effects. Am J Physiol 1968;214:406-13.
4. Hoane MR. Assessment of cognitive function following magnesium therapy in the traumatically injured brain. Magnes Res 2007;20:229-36.
5. Goni-de-Cerio F, Alvarez A, Lara-Celador I, et al. Magnesium sulfate treatment decreases the initial brain damage alterations produced after perinatal asphyxia in fetal lambs. J Neurosci Res 2012;90:1932-40.
6. Sameshima H, Ikenoue T. Long-term magnesium sulfate treatment as protection against hypoxic-ischemic brain injury in seven-day-old rats. Am J Obstet Gynecol 2001;184:185-90.
7. Esen F, Erdem T, Aktan D, et al. Effects of magnesium administration on brain edema and blood-brain barrier breakdown after experimental traumatic brain injury in rats. J Neurosurg Anesthesiol 2003;15:119-25.
8. Duley L, Gulmezoglu AM, Henderson-Smart DJ, et al. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2010;CD000025.
9. Nguyen TM, Crowther CA, Wilkinson D, et al. Magnesium sulphate for women at term for neuroprotection of the fetus. Cochrane Database Syst Rev 2013;2:CD009395.
10. Turkish Pharmaceutical Guide website. Available to (15.12.2018): https://www.ilacrehberi.com/v/pre-eklamolmagnezyum- sulfat-40-g1000-ml-iv-infuz-1036b/
11. Thurnau GR, Kemp DB, Jarvis A. Cerebrospinal fluid levels of magnesium in patients with preeclampsia after treatment with intravenous magnesium sulfate: a preliminary report. Am J Obstet Gynecol 1987;157:1435-8.
12. Fong J, Gurewitsch ED, Volpe L, et al. Baseline serum and cerebrospinal fluid magnesium levels in normal pregnancy and preeclampsia. Obstet Gynecol 1995;85:444-8.
13. Apostol A1, Apostol R, Ali E, et al. Cerebral spinal fluid and serum ionized magnesium and calcium levels in preeclamptic women during administration of magnesium sulfate. Fertil Steril 2010;94:276-82.
14. Sevene E, Lewin S, Mariano A, et al. Systems and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe. BMJ 2005;331:765-9.
15. Langer A, Villar J, Tell K, et al. Reducing eclampsia-related deaths - a call to action. Lancet 2008;371:705-6. 16. Neilson JP. Magnesium sulphate: the drug of choice in eclampsia. BMJ 1995;311:701-3.